3 Αποτελέσματα
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Application filed under 35 U.S.C. .sctn. 371 and claims priority to International Application No. PCT/KR/2015/004399, filed Apr. 30, 2015, which application claims priority to Korean Application No. 10-2014-0052728,
This application is the U.S. national phase of International Application No. PCT/KR2007/005454 filed 31 Oct. 2007 which designated the U.S., the entire contents of which is hereby incorporated by reference.
TECHNICAL FIELD
The present invention relates to a use of ginsenoside F1 obtained from a
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to nanoemulsion comprising metabolites of ginseng saponin as an effective component and to a method for preparing the same, and to a skin-care composition for anti-aging containing the same. More particularly, the